Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar Gel in Diabetic Nephropathy
NCT01601236Phase 2Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- May 2012
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of repository corticotropin injection in diabetic nephropathy (DN), sponsored by Mallinckrodt Pharmaceuticals. Started May 2012; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01601236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601236.